Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract
- Resource Type
- Article
- Source
- In
Gynecologic Oncology September 2020 158(3):570-575 - Subject
- Language
- ISSN
- 0090-8258